FDA Import Refusal AEK-2214280-5/60003/1 — GLENMARK PHARMACEUTICALS LTD
The FDA refused shipment AEK-2214280-5/60003/1 from GLENMARK PHARMACEUTICALS LTD (India) on Oct 6, 2026. The refused product falls under Drugs and Biologics — TELMISARTAN (ANTI-HYPERTENSIVE - PART II). Cited charges: 118,75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Oct 6, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 62ODA09 TELMISARTAN (ANTI-HYPERTENSIVE - PART II)
- Charges
- 118,75